Margolin Yael's most recent trade in POINT Biopharma Global Inc was a trade of 44,749 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 27, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
POINT Biopharma Global Inc | Yael Margolin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2023 | 44,749 | 0 | - | - | Stock Option (Right to Buy) | |
POINT Biopharma Global Inc | Margolin Yael | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2023 | 25,614 | 0 | - | - | Stock Option (Right to Buy) | |
POINT Biopharma Global Inc | Margolin Yael | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2023 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
POINT Biopharma Global Inc | Yael Margolin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2023 | 1,710 | 0 | - | - | Common Stock | |
POINT Biopharma Global Inc | Yael Margolin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 44,749 | 44,749 | - | - | Stock Option (Right to Buy) | |
POINT Biopharma Global Inc | Yael Margolin | Director | Purchase of securities on an exchange or from another person at price $ 6.56 per share. | 21 Nov 2022 | 1,710 | 1,710 | - | 6.6 | 11,218 | Common Stock |
POINT Biopharma Global Inc | Yael Margolin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 25,614 | 25,614 | - | - | Stock Option (Right to Buy) | |
POINT Biopharma Global Inc | Yael Margolin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |